These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 24270108

  • 1. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
    Park MJ, Kim YK, Park HJ, Hwang J, Lee WJ.
    J Comput Assist Tomogr; 2013; 37(6):872-81. PubMed ID: 24270108
    [Abstract] [Full Text] [Related]

  • 2. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ, Kim YK, Park MJ, Lee WJ.
    Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
    [Abstract] [Full Text] [Related]

  • 3. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Rhim HC.
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [Abstract] [Full Text] [Related]

  • 4. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Chong YS, Kim YK, Lee MW, Kim SH, Lee WJ, Rhim HC, Lee SJ.
    Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
    [Abstract] [Full Text] [Related]

  • 5. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 6. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ, Kim YK, Lee MH, Lee JH.
    Acta Radiol; 2013 Mar 01; 54(2):127-36. PubMed ID: 23148300
    [Abstract] [Full Text] [Related]

  • 7. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    Acta Radiol; 2012 Oct 01; 53(8):830-8. PubMed ID: 22847903
    [Abstract] [Full Text] [Related]

  • 8. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.
    Lim S, Kim YK, Park HJ, Lee WJ, Choi D, Park MJ.
    J Magn Reson Imaging; 2014 May 01; 39(5):1238-45. PubMed ID: 24136725
    [Abstract] [Full Text] [Related]

  • 9. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.
    Invest Radiol; 2010 Feb 01; 45(2):96-103. PubMed ID: 20057319
    [Abstract] [Full Text] [Related]

  • 10. Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum.
    Min JH, Kim YK, Choi SY, Jeong WK, Lee WJ, Ha SY, Ahn S, Ahn HS.
    Eur J Radiol; 2017 Jul 01; 92():1-10. PubMed ID: 28624005
    [Abstract] [Full Text] [Related]

  • 11. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
    Zhao XT, Li WX, Chai WM, Chen KM.
    J Dig Dis; 2014 Mar 01; 15(3):137-45. PubMed ID: 24354621
    [Abstract] [Full Text] [Related]

  • 12. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE, Kim SH, Lee SJ, Rhim H.
    AJR Am J Roentgenol; 2011 Jun 01; 196(6):W758-65. PubMed ID: 21606265
    [Abstract] [Full Text] [Related]

  • 13. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R, Lee JM, Shin CI, Lee ES, Yoon JH, Joo I, Kim SH, Hwang I, Han JK, Choi BI.
    Eur Radiol; 2016 Jun 01; 26(6):1808-17. PubMed ID: 26373763
    [Abstract] [Full Text] [Related]

  • 14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul 01; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 15. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Choi SY, Kim YK, Min JH, Kang TW, Jeong WK, Ahn S, Won H.
    Eur Radiol; 2018 Jun 01; 28(6):2549-2560. PubMed ID: 29335868
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging.
    Han SB, Kim YK, Min JH, Ha SY, Jeong WK, Lee WJ.
    Acta Radiol; 2018 Apr 01; 59(4):393-401. PubMed ID: 28760004
    [Abstract] [Full Text] [Related]

  • 17. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK, Kim CS, Han YM, Lee YH.
    Clin Radiol; 2011 Jun 01; 66(6):489-96. PubMed ID: 21367403
    [Abstract] [Full Text] [Related]

  • 18. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY, Kim SH, Lee WJ, Lim HK.
    Abdom Imaging; 2010 Jun 01; 35(3):337-45. PubMed ID: 19350315
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW.
    AJR Am J Roentgenol; 2011 Jul 01; 197(1):W44-52. PubMed ID: 21700994
    [Abstract] [Full Text] [Related]

  • 20. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y, Lee JM, Kim SH, Han JK, Choi BI.
    Radiology; 2012 Sep 01; 264(3):751-60. PubMed ID: 22798225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.